Mirum Pharmaceuticals Inc (NASDAQ:MIRM)
| 26.15 Delayed Data As of May 26 |  +0.08 / +0.31%Today’s Change | 17.32 Today|||52-Week Range 30.55 | +34.10% Year-to-Date |
Latest MIRM News | Press Releases
No recent news for Mirum Pharmaceuticals Inc.
Today’s Trading
| Previous close | 26.07 |
| Today’s open | 26.08 |
| Day’s range | 25.23 - 26.43 |
| Volume | 10,525 |
| Average volume (3 months) | 450,140 |
| Market cap | $994.5M |
Data as of 4:00pm ET, 05/26/2023
Growth & Valuation
| Earnings growth (last year) | -44.74% |
| Earnings growth (this year) | +24.74% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | +302.66% |
| P/E ratio | NM |
| Price/Sales | 8.56 |
| Price/Book | 6.80 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| KNSAKiniksa Pharmaceutic... | +0.30 | +2.18% |
| ---- | ||
| VRDNViridian Therapeutic... | -0.10 | -0.42% |
| ---- |
Data as of 3:59pm ET, 05/26/2023
Financials
| Next reporting date | August 30, 2023 |
| EPS forecast (this quarter) | -$0.82 |
| Annual revenue (last year) | $77.1M |
| Annual profit (last year) | -$135.7M |
| Net profit margin | -176.05% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Foster City, California |
Forecasts
